Ellison’s £118M Gift Ignites AI-Powered Vaccine Revolution at Oxford
A surprising wave of funding is speeding into the battle towards antibiotic-resistant illnesses: the Ellison Institute has granted £118 million to Oxford College’s Vaccine Group to kick off a five-year, AI-powered vaccine initiative focusing on pathogens like E. coli, pneumococcus, and staph—organisms which have stubbornly evaded conventional vaccination efforts. That is considered one of Oxford’s…
